Aurobindo Pharma This fall PAT up by 79% at ₹909 crore

Aurobindo Pharma has reported a internet revenue of ₹909 crore within the fourth quarter ending March 31, 2024, as in opposition to ₹506 crore in the identical quarter final 12 months, exhibiting a development of 79.6 per cent. The corporate registered a income of ₹7,580 crore within the quarter as in opposition to ₹6,473 within … Read more

Solar Pharma, Zydus, Cipla, Torrent Pharma, Dr. Reddy’s: How Indian pharma is Gearing Up for M&A

Torrent Pharma and Dr.Reddy’s eyeing promoter stake in Cipla would possibly simply be the beginning of an acquisition spree within the pharma area. We consider Indian Pharma could now flex its monetary muscle for each large and small offers, with sectoral sentiments on a excessive, stability sheets robust and all enterprise segments gathering momentum. Firms … Read more

Aurobindo Pharma subsidiary receives USFDA’s Institution Inspection Report; inventory rises over 4%

Aurobindo Pharma Ltd has knowledgeable the inventory exchanges that the corporate’s wholly-owned subsidiary APL Healthcare Ltd. has obtained institution inspection report (EIR) from the USFDA, classifying its manufacturing facility at Tirupati, Andhra Pradesh, as ‘voluntary motion indicated’ (VAI). The US FDA carried out an inspection on the firm’s unit located at Menakuru Village, Naidupeta Mandal, … Read more